Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-06-002797
Filing Date
2006-04-28
Accepted
2006-04-28 13:17:45
Documents
4
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS FORM 10K/A b60685a1e10vkza.htm 10-K/A 137469
2 EX-31.1 SECTION 302 CERTIFICATION OF MICHAEL J. ASTRUE b60685a1exv31w1.htm EX-31.1 7289
3 EX-31.2 SECTION 302 CERTIFICATION OF ROBERT B. PELLETIER b60685a1exv31w2.htm EX-31.2 7787
4 EX-32 SECTION 906 CERTIFICATION OF MICHAEL J. ASTRUE AND ROBERT B. PELLETIER b60685a1exv32.htm EX-32 5450
  Complete submission text file 0000950135-06-002797.txt   159457
Mailing Address 71 ROGERS ST CAMBRIDGE MA 02142-1118
Business Address 71 ROGERS ST CAMBRIDGE MA 02142-1118 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21863 | Film No.: 06788510
SIC: 2835 In Vitro & In Vivo Diagnostic Substances